Forum LABO Paris 2027

Conferences program

All sessions

The Forum LABO Paris 2027 program is taking shape!

Conferences, feedback sessions, and discussions with experts will explore the innovations, practices, and major challenges shaping the laboratory of tomorrow.

Our ambition: to bring together perspectives from research and industry to provide you with useful insights and practical solutions.

Discover the first sessions and check back regularly for updates.

Mar 23Mar 24Mar 25
Agora
Mar 23, 2027
10:00 AM11:30 AM
Innovation and scientific valorization

Opening conference - The laboratory in motion: how can we improve efficiency, strengthen reliability, and advance sustainable practices?

Description
Tight budgets, regulatory requirements, automation and artificial intelligence, resource optimization, environmental and climate imperatives... Laboratories must reconcile growing challenges while supporting their teams and preparing for the transformations of the coming years. • How can they innovate while keeping costs under control? • How can they automate while retaining control over operations? • How can they strengthen the reliability of results and reduce their environmental footprint with a constant budget? • How can they develop and retain the necessary skills without increasing pressure on teams? • Though these demands may seem contradictory, they can become drivers of progress. Drawing on feedback from laboratories that have successfully carried out transformations, this opening conference explores the technological, organizational, and human choices that are proving effective. Artificial intelligence, precision or miniaturized instrumentation, new sustainable practices: what concrete benefits can they deliver, what conditions are needed for success, and what impact will they have on professions and roles? Looking at yesterday’s choices to shed light on today’s decisions: which strategic shifts have paid off, which practices can be adapted to other organizations, and which directions should be taken as early as 2027?
Salle Marie Curie
Mar 23, 2027
2:00 PM3:00 PM
Biotechnology, science and healthcare of tomorrow

SCL

Description
Forensic science: analytical innovations serving justice, security and defense
Salle Marie Curie
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

HEMARINA

Description
More information coming soon.
Agora
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFSTP +POLEPHARMA

Salle Marie Curie
Mar 23, 2027
4:00 PM4:45 PM
Industry & materials

ESA

Description
Space and space biology
Salle Marie Curie
Mar 24, 2027
10:00 AM10:45 AM
Transition & regulation

EAU DE PARIS

Description
Water analysis: quality, monitoring and emerging contaminants
Agora
Mar 24, 2027
11:00 AM11:45 AM
Innovation and scientific valorization

CEEBIOS

Description
Biomimicry
Salle Marie Curie
Mar 24, 2027
11:00 AM11:45 AM
Laboratory transformationTransition & regulation

Food safety

Salle Marie Curie
Mar 24, 2027
12:00 PM12:45 PM
Transition & regulation

ASPEC

Agora
Mar 24, 2027
12:00 PM12:45 PM
Biotechnology, science and healthcare of tomorrow

New approaches to biopharmaceutical analysis - AFSEP

Description
Biopharmaceutical drugs are playing an increasingly important role in the pharmaceutical industry. This evolution is accompanied by a wide diversity of molecules, including monoclonal antibodies and their derivatives, oligonucleotides, messenger RNA, as well as cell and gene therapies. Their size, structure, and complexity make their analysis particularly challenging. Yet in-depth characterization is essential to verify their identity, purity, and integrity, detect variants and impurities, and better understand the links between their properties and their biological activity. This presentation will first cover the main families of biopharmaceuticals and the analytical challenges they raise. It will then show how different chromatographic approaches, with or without mass spectrometry, can contribute to their characterization. Examples will illustrate the complementarity of chromatographic modes, the development of rapid analyses, coupling with MS, and method automation. Finally, the biopharmaceuticals of tomorrow are expected to become even more complex, particularly with the rise of conjugated molecules combining several types of compounds. This evolution will require the continued development of adapted analytical strategies capable of providing ever more comprehensive and reliable information.
Agora
Mar 24, 2027
2:00 PM2:45 PM

CFM

Agora
Mar 24, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFM

Description
Microbiology, antimicrobial resistance and the One Health approach
Agora
Mar 24, 2027
4:00 PM4:45 PM
Industry & materials

ELRIGfr

Salle Marie Curie
Mar 25, 2027
10:00 AM10:45 AM
Biotechnology, science and healthcare of tomorrow

FRANCE BIOLEAD

Agora
Mar 25, 2027
11:00 AM11:45 AM

CFM

Salle Marie Curie
Mar 25, 2027
11:00 AM11:45 AM
Biotechnology, science and healthcare of tomorrow

POLEPHARMA

Agora
Mar 25, 2027
12:00 PM12:45 PM
Biotechnology, science and healthcare of tomorrow

FRANCE BIOVALLEY

Salle Marie Curie
Mar 25, 2027
2:00 PM3:00 PM

IRCGN